HOXB7 expression is a novel biomarker for long-term prognosis after resection of hepatocellular carcinoma

Hisateru Komatsu, Tomohiro Iguchi, Takaaki Masuda, Masami Ueda, Shinya Kidogami, Yushi Ogawa, Sho Nambara, Kuniaki Sato, Quingjang Hu, Tomoko Saito, Hidenari Hirata, Shotaro Sakimura, Ryutaro Uchi, Naoki Hayashi, Shuhei Ito, Hidetoshi Eguchi, Keishi Sugimachi, Yuichiro Doki, Masaki Mori, Koshi Mimori

研究成果: ジャーナルへの寄稿記事

5 引用 (Scopus)

抄録

Background/Aim: Homeobox B7 (HOXB7) gene is involved in various cellular functions. We investigated the clinical significance of HOXB7 expression in hepatocellular carcinoma (HCC). Materials and Methods: HOXB7 mRNA expression in 103 HCC samples and 58 matched noncancerous liver tissues were examined by quantitative realtime polymerase chain reaction (qRT-PCR). HOXB7 protein expression was also examined by immunohistochemistry. Gene set enrichment analysis (GSEA) was performed using a public dataset. Results: HOXB7 expression was significantly higher in HCC tissues than in liver parenchyma. Ten-year overall survival (OS) and 5-year recurrence-free survival (RFS) of cases with higher HOXB7 expression were significantly poorer than those with lower HOXB7 expression. HOXB7 expression was significantly associated with larger tumor size and higher rate of biliary invasion and constituted an independent prognostic factor for OS by multivariate analysis. These results were supported by GSEA. Conclusion: HOXB7 expression in HCC could be a novel biomarker for long-term prognosis after tumor resection.

元の言語英語
ページ(範囲)2767-2773
ページ数7
ジャーナルAnticancer research
36
発行部数6
出版物ステータス出版済み - 6 1 2016

Fingerprint

Homeobox Genes
Hepatocellular Carcinoma
Biomarkers
Homeodomain Proteins
Liver
Survival Analysis
Genes
Neoplasms
Multivariate Analysis
Immunohistochemistry
Recurrence
Polymerase Chain Reaction
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

これを引用

HOXB7 expression is a novel biomarker for long-term prognosis after resection of hepatocellular carcinoma. / Komatsu, Hisateru; Iguchi, Tomohiro; Masuda, Takaaki; Ueda, Masami; Kidogami, Shinya; Ogawa, Yushi; Nambara, Sho; Sato, Kuniaki; Hu, Quingjang; Saito, Tomoko; Hirata, Hidenari; Sakimura, Shotaro; Uchi, Ryutaro; Hayashi, Naoki; Ito, Shuhei; Eguchi, Hidetoshi; Sugimachi, Keishi; Doki, Yuichiro; Mori, Masaki; Mimori, Koshi.

:: Anticancer research, 巻 36, 番号 6, 01.06.2016, p. 2767-2773.

研究成果: ジャーナルへの寄稿記事

Komatsu, H, Iguchi, T, Masuda, T, Ueda, M, Kidogami, S, Ogawa, Y, Nambara, S, Sato, K, Hu, Q, Saito, T, Hirata, H, Sakimura, S, Uchi, R, Hayashi, N, Ito, S, Eguchi, H, Sugimachi, K, Doki, Y, Mori, M & Mimori, K 2016, 'HOXB7 expression is a novel biomarker for long-term prognosis after resection of hepatocellular carcinoma', Anticancer research, 巻. 36, 番号 6, pp. 2767-2773.
Komatsu, Hisateru ; Iguchi, Tomohiro ; Masuda, Takaaki ; Ueda, Masami ; Kidogami, Shinya ; Ogawa, Yushi ; Nambara, Sho ; Sato, Kuniaki ; Hu, Quingjang ; Saito, Tomoko ; Hirata, Hidenari ; Sakimura, Shotaro ; Uchi, Ryutaro ; Hayashi, Naoki ; Ito, Shuhei ; Eguchi, Hidetoshi ; Sugimachi, Keishi ; Doki, Yuichiro ; Mori, Masaki ; Mimori, Koshi. / HOXB7 expression is a novel biomarker for long-term prognosis after resection of hepatocellular carcinoma. :: Anticancer research. 2016 ; 巻 36, 番号 6. pp. 2767-2773.
@article{565ab4abbc0e4edf9d1209d2a4e36d7c,
title = "HOXB7 expression is a novel biomarker for long-term prognosis after resection of hepatocellular carcinoma",
abstract = "Background/Aim: Homeobox B7 (HOXB7) gene is involved in various cellular functions. We investigated the clinical significance of HOXB7 expression in hepatocellular carcinoma (HCC). Materials and Methods: HOXB7 mRNA expression in 103 HCC samples and 58 matched noncancerous liver tissues were examined by quantitative realtime polymerase chain reaction (qRT-PCR). HOXB7 protein expression was also examined by immunohistochemistry. Gene set enrichment analysis (GSEA) was performed using a public dataset. Results: HOXB7 expression was significantly higher in HCC tissues than in liver parenchyma. Ten-year overall survival (OS) and 5-year recurrence-free survival (RFS) of cases with higher HOXB7 expression were significantly poorer than those with lower HOXB7 expression. HOXB7 expression was significantly associated with larger tumor size and higher rate of biliary invasion and constituted an independent prognostic factor for OS by multivariate analysis. These results were supported by GSEA. Conclusion: HOXB7 expression in HCC could be a novel biomarker for long-term prognosis after tumor resection.",
author = "Hisateru Komatsu and Tomohiro Iguchi and Takaaki Masuda and Masami Ueda and Shinya Kidogami and Yushi Ogawa and Sho Nambara and Kuniaki Sato and Quingjang Hu and Tomoko Saito and Hidenari Hirata and Shotaro Sakimura and Ryutaro Uchi and Naoki Hayashi and Shuhei Ito and Hidetoshi Eguchi and Keishi Sugimachi and Yuichiro Doki and Masaki Mori and Koshi Mimori",
year = "2016",
month = "6",
day = "1",
language = "English",
volume = "36",
pages = "2767--2773",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - HOXB7 expression is a novel biomarker for long-term prognosis after resection of hepatocellular carcinoma

AU - Komatsu, Hisateru

AU - Iguchi, Tomohiro

AU - Masuda, Takaaki

AU - Ueda, Masami

AU - Kidogami, Shinya

AU - Ogawa, Yushi

AU - Nambara, Sho

AU - Sato, Kuniaki

AU - Hu, Quingjang

AU - Saito, Tomoko

AU - Hirata, Hidenari

AU - Sakimura, Shotaro

AU - Uchi, Ryutaro

AU - Hayashi, Naoki

AU - Ito, Shuhei

AU - Eguchi, Hidetoshi

AU - Sugimachi, Keishi

AU - Doki, Yuichiro

AU - Mori, Masaki

AU - Mimori, Koshi

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Background/Aim: Homeobox B7 (HOXB7) gene is involved in various cellular functions. We investigated the clinical significance of HOXB7 expression in hepatocellular carcinoma (HCC). Materials and Methods: HOXB7 mRNA expression in 103 HCC samples and 58 matched noncancerous liver tissues were examined by quantitative realtime polymerase chain reaction (qRT-PCR). HOXB7 protein expression was also examined by immunohistochemistry. Gene set enrichment analysis (GSEA) was performed using a public dataset. Results: HOXB7 expression was significantly higher in HCC tissues than in liver parenchyma. Ten-year overall survival (OS) and 5-year recurrence-free survival (RFS) of cases with higher HOXB7 expression were significantly poorer than those with lower HOXB7 expression. HOXB7 expression was significantly associated with larger tumor size and higher rate of biliary invasion and constituted an independent prognostic factor for OS by multivariate analysis. These results were supported by GSEA. Conclusion: HOXB7 expression in HCC could be a novel biomarker for long-term prognosis after tumor resection.

AB - Background/Aim: Homeobox B7 (HOXB7) gene is involved in various cellular functions. We investigated the clinical significance of HOXB7 expression in hepatocellular carcinoma (HCC). Materials and Methods: HOXB7 mRNA expression in 103 HCC samples and 58 matched noncancerous liver tissues were examined by quantitative realtime polymerase chain reaction (qRT-PCR). HOXB7 protein expression was also examined by immunohistochemistry. Gene set enrichment analysis (GSEA) was performed using a public dataset. Results: HOXB7 expression was significantly higher in HCC tissues than in liver parenchyma. Ten-year overall survival (OS) and 5-year recurrence-free survival (RFS) of cases with higher HOXB7 expression were significantly poorer than those with lower HOXB7 expression. HOXB7 expression was significantly associated with larger tumor size and higher rate of biliary invasion and constituted an independent prognostic factor for OS by multivariate analysis. These results were supported by GSEA. Conclusion: HOXB7 expression in HCC could be a novel biomarker for long-term prognosis after tumor resection.

UR - http://www.scopus.com/inward/record.url?scp=84991583744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991583744&partnerID=8YFLogxK

M3 - Article

C2 - 27272787

AN - SCOPUS:84991583744

VL - 36

SP - 2767

EP - 2773

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6

ER -